1 FDA Grants Breakthrough Therapy Designation to Mirum’s Volixibat for Cholestatic Pruritus in PBC thelansis.com Thelansis knowledge Partners 1 year ago in Business 0
1 Primary Biliary Cholangitis (PBC) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033 thelansis.com Thelansis knowledge Partners 2 years ago in Education 0